Notice of interim results
EKF Diagnostics Holdings PLC will release its interim results for the six months ending June 30, 2025, on Tuesday, September 16. The company will host a live online investor presentation on the same day at 10:30 am (BST) via the Investor Meet Company platform. A recording of the presentation, along with the slides and Q&A responses, will be available on the Investor Meet Company platform afterward.
Select text to share a quote on X · sign in to keep highlights & notes in your EKF notes
EKF Diagnostics Holdings plc (AIM: EKF), the AIM-quoted global diagnostics business, confirms it will announce its interim results for the six months ended 30 June 2025 on Tuesday 16 September.
Investor Presentation
EKF Diagnostics will be hosting a live online presentation open to all existing and potential investors on Tuesday 16 September 2025 at 10.30am (BST), via the Investor Meet Company platform. Investors can sign up to Investor Meet Company for free and add to meet EKF Diagnostics via:
| EKF Diagnostics Holdings plc | www.ekfdiagnostics.com |
| Julian Baines, Executive Chair | via Walbrook PR |
| Gavin Jones, Chief Executive Officer | |
| Stephen Young, Chief Financial Officer | |
| Singer Capital Markets (Nominated Adviser & Broker) | Tel: +44 (0)20 7496 3000 |
| Phil Davies / Oliver Platts | |
| Walbrook PR Limited | Tel: +44 (0)20 7933 8780 or ekf@walbrookpr.com |
| Paul McManus / Alice Woodings | Mob: +44 (0)7980 541 893 / +44 (0) 7407 804 654 |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.